New Antitrust Guidelines Broaden Scope of Regulation of the Pharma Sector
The Chinese State Council released theAnti-Monopoly Guidelines for the Pharmaceutical Sector (关于药品领域的反垄断指南) which took effect on January 24.
China increases regulatory framework for the pharma and life sciences sectors; Chinese authorities intervene to regulate VC funds management; and internet content providers could face stricter scrutiny on military-related content.

Subscribe to China Law & Practice today for:
Already a Subscriber? Log In. Sign In Now
Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)